ClinicalTrials.Veeva

Menu

The Association Between Monocyte Subsets and Coronary Collateral Development in Diabetes Mellitus

S

Samsun Education and Research Hospital

Status

Completed

Conditions

Coronary Artery Disease

Study type

Observational

Funder types

Other

Identifiers

NCT01671306
1037
Samsun EAH (Other Identifier)

Details and patient eligibility

About

Monocyte heterogeneity in peripheral blood seems to be important in coronary collateral development in non-diabetic patients with stable coronary artery disease. Our aim in this study is to find out any possible relationship between the levels of circulating monocyte subsets and coronary collateral development in type 2 diabetic patients.

Full description

83 diabetic patients with severe coronary artery disease were enrolled in the study. These patients were investigated according to their collateral development. Monocytes and their subtypes, namely CD14++CD16- and CD14+CD16+ cells were compared in 2 groups

Enrollment

83 patients

Sex

All

Ages

30 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • presence of > 95% stenosis of at least one major coronary artery in their first coronary angiogram.

Exclusion criteria

  • Patients experiencing acute coronary syndrome either with or without ST elevation in the last one month
  • Evidence of ongoing infection and inflammation, known malignancy and chronic kidney disease

Trial design

83 participants in 2 patient groups

Collateral, coronary disease
Description:
Patients are grouped into 2: Good and poor collateral development
collateral
Description:
Patients are grouped into 2: Good and poor collateral development

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems